POEMS syndrome with undetectable M-protein: a case report and literature review
- PMID: 38849857
- PMCID: PMC11157949
- DOI: 10.1186/s13000-024-01502-4
POEMS syndrome with undetectable M-protein: a case report and literature review
Abstract
Background: Polyneuropathy, organomegaly, endocrinopathy, M-protein, and skin changes (POEMS) syndrome is a rare plasma cell (PC) neoplasm with associated paraneoplastic syndrome. According to the current diagnostic criteria, peripheral polyneuropathy and monoclonal PC proliferative disorder represent two mandatory criteria.
Case presentation: We report a 54-year-old male with peripheral neuropathy of bilateral lower limbs, sclerotic bone lesions, elevated vascular endothelial growth factor (VEGF) levels, splenomegaly, extravascular volume overload, endocrinopathy, and skin hemangiomas. Of note, serum and urine protein electrophoresis (PEP) and immunofixation electrophoresis (IFE) of this patient indicated undetectable M-protein and the normal ratio of free light chains κ and λ (FLC-R (κ/λ)). No monoclonal PCs were found in bone marrow examinations or biopsy of diseased bones. However, his clinical manifestations matched most of the diagnostic criteria. After excluding other diseases that are easily confused with POEMS syndrome, the diagnosis of variant POEMS syndrome with undetectable M-protein was proposed. The patient obtained clinically significant improvement and elevated VEGF returned to normal after 6 months of treatment with lenalidomide plus dexamethasone.
Conclusions: Monoclonal PC dyscrasia (M-protein) while being a mandatory criterion for POEMS syndrome is undetectable in a considerable amount of patients that otherwise demonstrate typical symptoms. Here, we reported a case of variant POEMS syndrome with featured clinical manifestations, elevated VEGF levels, and good response to therapies targeting PCs but no evidence of M-protein. Therefore, negative results in M-protein and monoclonal PCs aren't enough to reject the diagnosis of POEMS syndrome. It is imperative to recognize the variant form of POEMS syndrome.
Keywords: Diagnosis; M-protein; POEMS syndrome; Plasma cell.
© 2024. The Author(s).
Conflict of interest statement
The authors declare no competing interests.
Figures





Similar articles
-
Diagnostic Challenges of Polyneuropathy, Organomegaly, Endocrinopathy, M-protein, and Skin Changes (POEMS) Syndrome: A Rare Case Report and Review of the Literature.Cardiovasc Hematol Disord Drug Targets. 2025 Mar 13. doi: 10.2174/011871529X352283250305042317. Online ahead of print. Cardiovasc Hematol Disord Drug Targets. 2025. PMID: 40143390
-
Leave It to the Prose: A Case of POEMS Syndrome.Cureus. 2021 Oct 11;13(10):e18664. doi: 10.7759/cureus.18664. eCollection 2021 Oct. Cureus. 2021. PMID: 34790444 Free PMC article.
-
Clinical characteristics and the long-term outcome of patients with atypical POEMS syndrome variant with undetectable monoclonal gammopathy.Ann Hematol. 2019 Mar;98(3):735-743. doi: 10.1007/s00277-018-03589-4. Epub 2019 Jan 5. Ann Hematol. 2019. PMID: 30612232
-
[Rapid improvement of fluid retention with lenalidomide plus low-dose dexamethasone for POEMS syndrome relapsed after autologous peripheral blood stem cell transplantation].Rinsho Ketsueki. 2013 Jul;54(7):670-4. Rinsho Ketsueki. 2013. PMID: 23912352 Review. Japanese.
-
POEMS Syndrome: 2019 Update on diagnosis, risk-stratification, and management.Am J Hematol. 2019 Jul;94(7):812-827. doi: 10.1002/ajh.25495. Epub 2019 May 23. Am J Hematol. 2019. PMID: 31012139 Review.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous